News from d-pharm ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 18, 2014, 08:00 ET

D-Pharm Achieves Primary End-point in Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated With tPA

D-Pharm Ltd. (TASE: DPRM) reported today, December 18th, 2014, that its Phase 2 clinical study of THR-18 successfully achieved its primary...

Dec 16, 2014, 08:00 ET

Yew Bio-Pharm to Enter U.S. Health Supplement Market With Two New Agaric Polysaccharide Products Focused on Enhancing Immunity

 Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), today announced that it is entering into the U.S. health supplement...

Nov 17, 2014, 09:30 ET

Yew Bio-Pharm Group Reports Improved Financial Results For 2014 Third Quarter

 Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Nov 04, 2014, 09:30 ET

Yew Bio-Pharm Establishes New Subsidiary to Focus on Organic Foods and Functional Beverages

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), today announced the creation of a new subsidiary, Harbin Yew Food Co. LTD.,...

Nov 04, 2014, 08:51 ET

D-Pharm Reports First Results From its Phase 2 Clinical Study of THR-18 In Acute Stroke Patients Treated with tPA

D-Pharm Ltd (TASE: DPRM) reported today, November 4th, 2014, top-line safety results following completion of its Phase 2 clinical study of THR-18...

Oct 30, 2014, 09:30 ET

Yew Bio-Pharm Applauds China State Forestry Administration's Creation of Subsidies to Encourage Chinese Medicinal Herb Crops

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Oct 15, 2014, 02:32 ET

ScinoPharm Recognized as API Supplier of the Year at Global Generics & Biosimilars Awards

ScinoPharm (TWSE:1789) announced that it was named the "Active Pharmaceutical Ingredient (API) Supplier of the Year" at the Global Generics and...

Oct 13, 2014, 08:05 ET

Yew Bio-Pharm Signs Exclusive Distribution Agreement with Carpal Aid to Market Carpal Tunnel Syndrome Product in China

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Aug 14, 2014, 16:05 ET

Yew Bio-Pharm Group Reports 2014 Second Quarter Financial Results

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Jul 15, 2014, 08:00 ET

Yew Bio-Pharm Welcomes Two New Board Members

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Jun 12, 2014, 08:00 ET

D-Pharm's DP-b99 Prevents Abnormal Neuronal Plasticity and Pathological Brain Reorganization

D-Pharm Ltd. (TASE: DPRM) announced today, publication in PLOS ONE, of promising results from a study of its drug candidate DP-b99. The findings...

Jun 02, 2014, 08:00 ET

D-Pharm Reports Completion of the Second Dose Tier in its Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated with the Thrombolytic Drug tPA

D-Pharm Ltd. (TASE: DPRM), Rehovot, Israel, reports today, June 2nd, 2014, the interim results for the second dose tier of stroke patients that...

May 21, 2014, 08:00 ET

Yew Bio-Pharm Group Reports 2014 First Quarter Financial Results

HARBIN, China, May 21, 2014 /PRNewswire/ -- Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of...

Mar 31, 2014, 16:05 ET

Yew Bio-Pharm Group Reports 2013 Fourth Quarter And Full Year Financial Results

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Mar 04, 2014, 08:00 ET

D-Pharm Reports the Successful Interim Analysis of its Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated With the Thrombolytic Drug tPA

D-Pharm Ltd (TASE: DPRM) announced today, March 4th, 2014, the successful interim analysis of the first group of stroke patients that completed...

Jan 23, 2014, 18:43 ET

Yew Bio-Pharm Chairman & CEO Issues Letter to Shareholders

Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCQB: YEWB), a major grower and seller of yew trees, yew raw materials used in the...

Jan 21, 2014, 08:00 ET

D-Pharm Completes Recruitment of Patients into the first Dosage Tier of its Phase 2 Study with THR-18 in Acute Stroke Patients Treated with tPA

D-Pharm Ltd (TASE: DPRM) announced today, January 21st, 2014, that enrolment of patients into the first tier of its Phase 2 clinical trial with...

Jan 14, 2014, 08:00 ET

D-Pharm Announces Recruitment of the First Patient Into Its Phase 2 Clinical Trial With DP-b99 in Acute High-Risk Pancreatitis

D-Pharm Ltd (TASE: DPRM) announced today January 14th 2014, that the first patient has been recruited into its Phase 2 clinical trial of DP-b99 in...

Nov 21, 2013, 08:00 ET

D-Pharm starts Phase 2 Clinical Study with DP-b99 in Acute High-Risk Pancreatitis Patients

D-Pharm Ltd (TASE:DPRM) announced today November 21st 2013, receipt of approval from the regulatory authorities in Slovakia to commence a Phase 2...

Oct 30, 2013, 09:01 ET

D-Pharm Granted Patent in US and China for its Phase II Product THR-18

D-Pharm Ltd (TASE: DPRM) announced today, October 30 2013, that a new patent has been granted in the US and China related to composition and use...